Distributors / Reps

Find out how IMDA can help you achieve excellence in specialty sales and marketing.


Meet an IMDA Member

Bell Medical Logo

Bell Medical

1728 Macklind Avenue, St. Louis, MO  63110

Contact: Kevin Lueders

Primary specialties: Anesthesia, Respiratory, Critical Care, Emergency and GI/Endoscopy

Territory: USA Nationwide and Canada

Biggest challenge in next 12 months:  Adding and training new sales representatives.  Meeting the demands and exceeding the goals of the manufacturers we represent. 

Biggest opportunity in next 12 months: Expanding sales success of the Xavant Stimpod NMS 450 and other new products such as Alar Nasal Sensor, TriggerNeb, Pulmodyne, Patient Positioning Systems, eMac and Amsorb Plus

IMDA eNews   8/9/16                              Subscribe

  • The new CMS star ratings program is confusing for patients and families trying to choose the best hospital to meet their health care needs,  said American Hospital Association President and CEO Rick Pollack, in a July 27 statement. Health care consumers making critical decisions about their care cannot be expected to rely on a rating system that raises far more questions than answers. The Centers for Medicare & Medicaid Services would respectfully disagree. The Overall Hospital Quality Star Rating summarizes data from existing quality measures publicly reported on Hospital Compare into a single star rating for each hospital, making it easier for consumers to compare hospitals and interpret complex quality information, says CMS.

    Researchers at the Technion-Israel Institute of Technology have developed a life-sized artificial human lung, reportedly the first diagnostic tool for understanding in real time how tiny particles move and behave in the deepest part of the human lungs (alveolar tissue). The patented platform could provide a better understanding of the health risks associated with airborne pollution, and be used for the evaluation and design of drugs for the respiratory system. The results were published recently in Scientific Reports.
    Hospitals are just starting to come to grips with the reality that they must pay attention to patient-reported outcomes, but they have a lot of catching up to do, reports MedCity News. Just 18 percent of hospitals always consult patient-reported outcomes when making clinical decisions and setting care guidelines, according to a survey of hospital executives, conducted by Salt Lake City-based analytics firm Health Catalyst. Still, that is a higher rate than some expected.

     Ten medical technology startups to watch, per the editors of Medical Design & Outsourcing: Amphora Medical (technology to treat overactive bladder); Aum Cardiovascular (hand-held heart disease diagnostic device); Bigfoot Biomedical (artificial pancreas); Cardialen (low-energy implant for atrial fibrillation); InterValve Inc. (aortic valvuloplasty balloon for treatment of calcific aortic stenosis); Mardil Medical (treatment for functional mitral valve regurgitation, or FMR); MIVI Neuroscience (catheter-based treatment for acute ischemic stroke); Pursuit Vascular (protects hemodialysis patients from bloodstream infections); Sonex Health (reduces size of incision for carpal tunnel syndrome surgery); TriFusion Devices (3D-printed prosthetic devices).

    Subscribe me to the IMDA eNews Weekly Newsletter